Micro Syringes Market Segmentation:
Needle Type Segment Analysis
The removable sub-segment in the needle type segment is predicted to dominate over 65% market share by the end of 2035. Removable needles are reusable in nature and it is available in different sizes. They are also available in different customizations and different point styles. Owing to all such qualities, they are widely preferred by inexperienced users.
End-User Segment Analysis
The laboratories segment with a share of 35% is poised to lead the market of micro syringes by 2035. This is attributed to the increasing laboratory research activities throughout the globe and the increasing usage of micro syringes in laboratories for drawing up and expelling liquids or suspensions facilitating such research works.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Needle Type |
|
|
End User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of micro syringes is estimated at USD 283.04 million.
The global micro syringes market size was more than USD 267.4 million in 2025 and is anticipated to grow at a CAGR of over 6.5%, reaching USD 501.95 million revenue by 2035.
North America in the micro syringes market is anticipated to command the largest revenue share of 35% by 2035, attributable to the United States accounting for nearly 41% of global pharmaceutical spending and accelerating regional market expansion.
Key players in the market include Brother Enterprises Holding Co., Ltd., BASF SE, Jiangxi Tianxin Pharmaceutical Co., Ltd., Koninklijke DSM N.V., Supreem Pharmaceuticals Mysore Pvt. Ltd., Saltvae Pharmaceuticals Private Limited, Charles Bowman and Company, Huazhong Pharmaceutical Co., Ltd., Xinfa Pharmaceutical Co. Ltd., CMG BIOTECH PRIVATE LIMITED.
